Navigation Links
Blue Cross Blue Shield of North Carolina Implements Aggressive Generic Medication Campaign
Date:4/16/2008

The Plan Moves More than 40 Tier 3 Drugs for Chronic Diseases to Tier 2,

According to a New Report from HealthLeaders-InterStudy

NASHVILLE, Tenn., April 16 /PRNewswire/ -- HealthLeaders-InterStudy, the leading provider of managed care market intelligence, reports that Blue Cross and Blue Shield of North Carolina has begun an aggressive generic medication campaign as of January 2008 in which it waives the copayment on all generic drugs that treat congestive heart failure, high blood pressure, high cholesterol and diabetes. According to the new report entitled Blue Profiler: Blue Cross and Blue Shield of North Carolina, the campaign, called Medication Dedication, is the plan's attempt to encourage members to take prescription drugs as directed and to make the overall cost of drugs more affordable.

"In 2007, Blue Cross and Blue Shield of North Carolina's generic utilization rate was higher than its two major competitors, UnitedHealthcare and CIGNA Healthcare," said Heather Wicks, analyst at HealthLeaders- InterStudy. "The Blue Plan's rate was 58 percent in 2007, up from 46.8 percent in 2004."

The report also finds that Blue Cross and Blue Shield of North Carolina has moved more than 40 drugs to treat chronic diseases from Tier 3 to Tier 2 as part of its Medication Dedication program. For example, Tier 3 drugs to treat diabetes moved to Tier 2 status include Byetta, Fortamet, Glucagen, Glumetza, Glyset, Prandin, Riomet, Starlit and Symlin.

"Blue Cross Blue Shield of North Carolina had been more aggressive than competitors CIGNA Healthcare and UnitedHealthcare in the placement of more expensive brand-name drugs in tiers requiring higher copays," continued Ms. Wicks. "However, the decision to move more drugs to lower tiers in 2008 should put Blue Cross Blue Shield of North Carolina more in line with other payers."

Blue Profiler: Blue Cross and Blue Shield of North Carolina is one of 15 2008 Blue Profiler reports on the nation's largest nonprofit Blue Cross Blue Shield plans, which together insure more than 50 million people.

About Blue Profiler

Blue Profiler offers the most comprehensive analysis of the nonprofit Blue Cross Blue Shield plans. Each report includes an individual nonprofit Blue plan and includes valuable analysis that will allow companies to more effectively partner with these dominant organizations. Each report includes information on:

-- Competitive analysis

-- Enrollment trends

-- Company-wide financials

-- HMO financials

-- Consumer-driven products

-- Medicare strategy

-- Pharmacy

-- Disease Management

About HealthLeaders-InterStudy

HealthLeaders-InterStudy (http://www.hl-isy.com) is the authoritative source for managed care data and analysis. HealthLeaders-InterStudy is a Decision Resources, Inc. company.

All company, brand, or product names contained in this document may be

trademarks or registered trademarks of their respective holders.

For more information, contact:

Elizabeth Marshall

Decision Resources, Inc.

781-296-2563

emarshall@dresources.com


'/>"/>
SOURCE HealthLeaders-InterStudy
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Using HR Performance Metrics to Drive Costs Down Across HR Functions
2. Cedar Point to Host 17th Annual Red Cross Miniature Golf Event
3. Two Men to Walk Across America for Autism Aid, Awareness, and Loving Memory of Young Boy
4. Polar Introduces Cost-Effective Solution to Reduce Heart Rate Data Cross-Talk
5. Kids With Cell Phones Not as Safe Crossing Streets
6. Blue Cross and Blue Shield of Oklahoma Launches an Integrated Medical-Dental Health Program
7. Anthem Blue Cross Tackles Childhood Obesity in California Through Free BMI Workshops for Pediatric and Family Medicine Health Care Providers
8. Business Leader, Nonprofit Volunteer to Head the American Red Cross
9. Researchers Able to Continue their Work to Help Patients Thanks to McDevitt Excellence in Research Awards from Blue Cross Blue Shield of Michigan Foundation
10. Daniel Corcoran named President of Anthem Blue Cross and Blue Shield in Maine
11. Partnership for Prescription Assistance Celebrates Three Year Anniversary; Helps Nearly 5 Million Uninsured Patients Across United States
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... ... 28, 2017 , ... It's not always common knowledge whether or not a ... unclear as to whether or not they are contagious, and most people don't know ... So, FindaTopDoc took a look into the matter. , They discovered that the ...
(Date:4/28/2017)... New York, NY (PRWEB) , ... April 28, ... ... Shiel Medical Laboratory to expanded distribution of the GlycoMark test throughout the Northeast ... indicates recent hyperglycemia in patients with diabetes. The GlycoMark test provides a clinically ...
(Date:4/28/2017)... , ... April 28, 2017 , ... ... been previously exposed to more adverse experiences than children in the general population. ... such as abuse, neglect or other family challenges. While no fault of their ...
(Date:4/28/2017)... ... ... Bill Howe started his sewer and drain company in 1980 focusing heavily ... team, the Bill Howe brand was born and they began cultivating their mission to ... the San Diego community in which they worked, lived and were raising their daughters. ...
(Date:4/28/2017)... ... April 28, 2017 , ... Woolsy Corporation ... supplements, through its Nova Skin Sciences division, recently announced the launch of Allumière ... with the power of an anti-aging concentrate. , Anogeissus Leiocarpa Bark ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... Texas , April 20, 2017  Vivify Health, ... mobile devices, has been awarded a very significant patent ... via EMRs to continual care via digital health.  This ... key intellectual property and further secures Vivify,s position as ... launched in 2009, was the first company to apply ...
(Date:4/20/2017)... 2017  RXi Pharmaceuticals Corporation (NASDAQ: RXII), a ... significant unmet medical needs, today announced that it ... product development program, based on its proprietary self-delivering ... Dermatology (SID) 76 th Annual Meeting.  The ... sciences relevant to skin health and disease through ...
(Date:4/20/2017)... , April 20, 2017   ZappRx, Inc ., ... specialty drug prescribing process, today announced it closed $25 million ... a venture capital firm based in Seattle ... Qiming Venture Partners . The Series B round included participation ... round in 2014, and GV (formerly Google Ventures). ...
Breaking Medicine Technology: